Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, looking exclusively at women.
Ipsen extends Marengo partnership with $1.2bn T cell research deal – Pharmaceutical Technology
T cells express a receptor with the potential to recognise diverse antigens from pathogens, tumours, and the environment. Credit: Design_Cells via Shutterstock. France-headquartered Ipsen has
June 10, 2024